Methamphetamine and cannabis abuse in adolescence: A quasi-experimental study on specific and long-term neurocognitive effects

BMJ Open

Volumn 5, Issue 1, 2015, Pages

  Cuzen, Natalie L ^a   Koopowitz, Sheri Michelle ^a   Ferrett, Helen L ^b   Stein, Dan J ^a   Yurgelun Todd, Deborah ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; METHAMPHETAMINE; NICOTINE;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; CANNABIS ADDICTION; CANNABIS USE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; METHAMPHETAMINE DEPENDENCE; POSTTRAUMATIC STRESS DISORDER; QUASI EXPERIMENTAL STUDY; SUBSTANCE ABUSE; SUBSTANCE USE; VERBAL MEMORY; VISUAL MEMORY; AMPHETAMINE DEPENDENCE; COGNITION DISORDERS; COMORBIDITY; MARIJUANA ABUSE; NEUROPSYCHOLOGICAL TEST; SOUTH AFRICA;

ADOLESCENT; ADOLESCENT BEHAVIOR; AMPHETAMINE-RELATED DISORDERS; COGNITION DISORDERS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MARIJUANA ABUSE; NEUROPSYCHOLOGICAL TESTS; SOUTH AFRICA;

EID: 84922370042     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005833     Document Type: Article

References (44)

1. Chu P-W, Seferian KS, Birdsall E, et al. Differential regional effects of methamphetamine on dopamine transport. Eur J Pharmacol 2008;590:105-10.
2. Chang L, Alicata D, Ernst T, et al. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007;102:16-32.
3. Eckstrand KL, Ding Z, Dodge NC, et al. Persistent dose-dependent changes in brain structure in young adults with low-to-moderate alcohol exposure in utero. Alcohol Clin Exp Res 2012;36:1892-902.
4. Schwendt M, Rocha A, See RE, et al. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 2009;331:555-62.
5. McCann UD, Kuwabara H, Kumar A, et al. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 2008;62:91-100.
6. Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J Neuropsychiatry Clin Neurosci 2003;15:317-25.
7. Vorhees CV, Skelton MR, Grace CE, et al. Effects of (+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. Int J Dev Neurosci 2009;27:289-98.
8. Derauf C, LaGasse LL, Smith LM, et al. Prenatal methamphetamine exposure and inhibitory control among young school-age children. J Pediatr 2012;161:452-9.
9. Lu LH, Johnson A, O'Hare ED, et al. Effects of prenatal methamphetamine exposure on verbal memory revealed with fMRI. J Dev Behav Pediatr 2009;30:185-92.
10. Smith LM, LaGasse LL, Derauf C, et al. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol 2011;33:176-84.
11. Crane NA, Schuster RM, Fusar-Poli P, et al. Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 2013;23:117-37.
12. Dean AC, Groman SM, Morales AM, et al. An evaluation of the evidence that methamphetamine abuse causes cognitive declines in humans. Neuropsychopharmacology 2013;38:259-74.
13. Lisdahl KM, Gilbart ER, Wright NE, et al. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry 2013;4:53.
14. King G, Alicata D, Cloak C, et al. Neuropsychological deficits in adolescent methamphetamine abusers. Psychopharmacology (Berl) 2010;212:243-9.
15. Andersen SL. Stimulants and the developing brain. Trends Pharmacol Sci 2005;26:237-43.
16. Lubman DI, Yücel M, Hall WD. Substance use and the adolescent brain: A toxic combination? J Psychopharmacol 2007;21:792-4.
17. Scott JC, Woods SP, Matt GE, et al. Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychol Rev 2007;17:275-97.
18. Plüddemann A, Myers BJ, Parry CDH. Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health. Drug Alcohol Rev 2008;27:185-9.
19. Agrawal A, Neale MC, Prescott CA, et al. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behav Genet 2004;34:217-28.
20. Churchwell JC, Carey PD, Ferrett HL, et al. Abnormal striatal circuitry and intensified novelty seeking among adolescents who abuse methamphetamine and cannabis. Dev Neurosci 2012;34:310-17.
21. Couwenbergh C, van den Brink W, Zwart K, et al. Comorbid psychopathology in adolescents and young adults treated for substance use disorders: A review. Eur Child Adolesc Psychiatry 2006;15:319-28.
22. Kaufman J, Birmaher B, Brent D, et al. The Schedule for Affective Disorders and Schizophrenia for School Aged Children (6-18 years) Lifetime Version. Retrieved 25 March 2010, from University of Pittsburgh, Department of Psychiatry. http://www.wpic.pitt.edu\ksads.
23. American Psychiatric Association. DSM-IV-TR: diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Publishing, 2000.
24. Fein G, Di Sclafani V, Finn P, et al. Sub-diagnostic psychiatric comorbidity in alcoholics. Drug Alcohol Depend 2007;87:139-45.
25. Di Sclafani V, Finn P, Fein G. Treatment-naive active alcoholics have greater psychiatric comorbidity than normal controls but less than treated abstinent alcoholics. Drug Alcohol Depend 2008;98:115-22.
26. Clark DB, Cornelius JR, Kirisci L, et al. Childhood risk categories for adolescent substance involvement: A general liability typology. Drug Alcohol Depend 2005;77:13-21.
27. American Psychiatric Association. DSM-5: diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Publishing, 2013.
28. March JS. Multidimensional anxiety scale for children: Technical manual. Toronto, ON: Multi-Health Systems, 1997.
29. Foxcroft C, Paterson H, le Roux N, et al. Psychological assessment in South Africa: A needs analysis. The test use patterns and needs of psychological assessment practitioners. Pretoria: Human Sciences Research Council, 2004.
30. van Ommen CH. Putting the PC in IQ: images in the Wechsler Adult Intelligence Scale-third edition (WAIS-III). S Afr J Psychol 2005;35:532-54.
31. Llorente AM, Williams J, Satz P, et al. Children's color trails test: professional manual. Odessa: Psychological Assessment Resources, 2003.
32. Cohen M. Chuldren's memory scale: manual. San Antonio, TX: The Psychological Corporation, 1997.
33. Maj M, D'Elia L, Satz P, et al. Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: A WHO study. Arch Clin Neuropsychol 1993;8:123-35.
34. Russell EW, Starkey RI. Halstead Russell Neuropsychological Evaluation System (HRNES). Los Angeles, CA: Western Psychological Services, 1993.
35. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corp, 1999.
36. Meyers J, Meyers K. Rey Complex figure and the recognition trial: professional manual. Supplemental norms for children and adolescents. Odessa: Psychological Assessment Resources, 1996.
37. Culbertson WC, Zillmer EA. Tower of London: Technical manual. New York, NY: Multi-Health Systems Inc, 2001.
38. World Medical Association. Declaration of Helsinki 52nd WMA General Assembly. Edinburgh, Scotland, 2000.
39. Medina KL, Hanson KL, Schweinsburg AD, et al. Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc 2007;13:807-20.
40. Lezak M, Howieson D, Loring D. Neuropsychological assessment. New York, NY: Oxford University Press, 2004.
41. Bortolato M, Frau R, Bini V, et al. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB1 cannabinoid receptors. J Psychiatr Res 2010;44:944-55.
42. Gonzalez R, Rippeth JD, Carey CL, et al. Neurocognitive performance of methamphetamine users discordante for history of marijuana exposure. Drug Alcohol Depend 2004;76:181-90.
43. Sung YH, Carey PD, Stein DJ, et al. Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana. Behav Brain Res 2013;1246:154-61.
44. Volkow ND, Chang L, Wang GJ, et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001;21:9414-18.